Translate
Text Highlighter

Bookmark

PDF

Share

Report a problem
AMICUS AI
Citation Codes
Equivalent Citations
citation codes
Case Number
Advocates
Judges
Acts
  • provisions of section 25(3)(4) of the Drugs and Cosmetics Act, 1940,
  • section 25(3) and (4) of the Drugs and Cosmetics Act, 1940,
  • provisions of the Drugs and Cosmetics Act and Rules.
  • Government Analysts. Sub-section (3) of section 25
  • provisions of sub-section (3) of section 25,
  • SECTION 27 A DRUGS AND COSMETICS ACT
  • report.12. Sub-section (3) of section 25
  • DRUGS AND COSMETICS ACT
  • section 18(a)(i) read with section 16
  • sub-section (4) of section 23
  • sub-section (3) of section 25
Are you a practicing lawyer?
Enhance your digital presence and reach by creating a Casemine profile.
Upload pleading to use the new AI search
Cites
Cited by
Citation Codes
Equivalent Citations
citation codes
Case Number
Advocates
Judges
Acts
  • provisions of section 25(3)(4) of the Drugs and Cosmetics Act, 1940,
  • section 25(3) and (4) of the Drugs and Cosmetics Act, 1940,
  • provisions of the Drugs and Cosmetics Act and Rules.
  • Government Analysts. Sub-section (3) of section 25
  • provisions of sub-section (3) of section 25,
  • SECTION 27 A DRUGS AND COSMETICS ACT
  • report.12. Sub-section (3) of section 25
  • DRUGS AND COSMETICS ACT
  • section 18(a)(i) read with section 16
  • sub-section (4) of section 23
  • sub-section (3) of section 25
Smart Summary

Structured Summary of the Opinion

Factual and Procedural Background

This matter arises from a Criminal Writ Petition challenging the order dated 3-2-1998 of the 3rd Additional Sessions Judge, Nagpur, which dismissed a revision against the order dated 24-10-1994 of the Additional Chief Judicial Magistrate, Nagpur in Complaint (Cr.) Case No. 21 of 1994.

Petitioner No.1 is a public limited company manufacturing medicines (including Ampicillin and Cloxacillin capsules marketed as "Zimlox"). The complainant is a Drug Inspector empowered under the Drugs and Cosmetics Act and Rules.

Relevant timeline and procedural events (as described in the opinion):

  • Sample was drawn on 26-10-1993.
  • Report of the Government Analyst was received by the Drug Inspector on 8-2-1994.
  • A copy of that analyst's report was supplied to the accused (petitioner company) on 26-5-1994.
  • On 26-5-1994 the Drug Inspector handed over the report and analysis stating the sample was "not of standard quality."
  • Petitioner sent written intimation to the Drug Inspector on 18-6-1994, within 28 days of receiving the report copy, notifying intention to adduce evidence in controversion and requesting reanalysis at the Central Drugs Laboratory (willing to bear costs).
  • The Drug Inspector forwarded the remaining sample and papers to the Joint Commissioner, who on 13-7-1994 advised the petitioner to approach the Court for directions to send the sample to the Central Drugs Laboratory, Calcutta.
  • Petitioner presented Criminal Application No. 12 of 1994 on 28-7-1994 before the Additional Chief Judicial Magistrate requesting direction for reanalysis; the Magistrate issued notice returnable on 30-9-1994.
  • The Drug Inspector did not promptly submit the sample to Court; on 31-8-1994 the Drug Inspector lodged the criminal complaint against petitioners under section 18(a)(i) read with section 16 and punishable under section 27 of the Drugs and Cosmetics Act.
  • The Magistrate by order dated 24-10-1994 rejected petitioners' application to dismiss the complaint and discharge the accused. That order was affirmed by the Revisional Court on 3-2-1998. The petitioners filed the present writ petition challenging those rulings.

Legal Issues Presented

  1. Whether, having notified the Drug Inspector in writing within 28 days of receipt of the Government Analyst's report (under section 25(3) of the Drugs and Cosmetics Act, 1940), the petitioners were deprived of their statutory right to obtain reanalysis at the Central Drugs Laboratory due to inaction by the Drug Inspector and thereby entitled to dismissal of the prosecution.
  2. Whether the accused's conduct (delay in approaching the Court for directions to send the sample for reanalysis) amounted to wilful delay disentitling them from the benefit of section 25(3) and (4) of the Act, as contended by the State.
  3. Whether the impugned orders (Magistrate's order dated 24-10-1994 and the Revisional Court's order dated 3-2-1998) were legally maintainable in view of the statutory scheme in sections 23 and 25 of the Act and the authorities relied upon.

Arguments of the Parties

Petitioners' Arguments

  • The prosecution is vitiated because the Drug Inspector failed to follow provisions of section 25(3) and (4) of the Drugs and Cosmetics Act, 1940, depriving the petitioners of the statutory right to reanalysis at the Central Drugs Laboratory.
  • The petitioners received the Government Analyst's report copy on 26-5-1994 and within 28 days (by letter dated 18-6-1994) informed the Drug Inspector of their intention to adduce evidence in controversion and requested reanalysis; therefore the requirements of section 25(3) were satisfied.
  • Either the Drug Inspector should have immediately sought the Magistrate's direction for reanalysis, or the Magistrate could have directed reanalysis when petitioners sought relief in Criminal Application No.12 of 1994; the failure to act was fatal to the prosecution.
  • Because of the above failures, the prosecution was rendered unsustainable and the complaint ought to be dismissed.

Respondent-State's Arguments

  • The petitioners caused a wilful and unreasonable delay in approaching the Court for direction to send the sample to the Central Drugs Laboratory; the petitioners received the report copy on 26-5-1994 and waited until 28-7-1994 to move the Court.
  • The delay was deliberate and intended to allow time to lapse (the drug was due to expire in August 1994), so petitioners should not be entitled to the benefit of sections 25(3) and (4) of the Act.
  • Accordingly, the impugned order dismissing challenges to the prosecution was proper.

Table of Precedents Cited

Precedent Rule or Principle Cited For Application by the Court
AIR 1967 SC 970, Municipal Corporation of Delhi v. Ghisa Ram The opinion reproduces para 7 of this judgment: a vendor's (or accused's) valuable right to have a sample analysed by the Director of the Central Laboratory is to be protected; the Director's certificate supersedes the Public Analyst's report and is treated as conclusive; deliberate conduct of the prosecution that denies this right seriously prejudices the accused. The Court held that the present controversy was clearly covered by the observations in Ghisa Ram, applied those observations to conclude that the petitioners had been deprived of a valuable statutory right because of prosecutorial/inspector inaction, and relied on that principle in quashing the complaint.
1997 (2) Mh. L.J. 629, Ramanbhai v. S.R. Sharma Cited by the petitioners through their counsel; the opinion records reliance but does not set out the specific rule or reasoning from this authority. The opinion notes the reliance placed on this decision by petitioners' counsel but does not otherwise discuss or apply any specific excerpt from it in its reasoning.
1995 Drugs Cases 72, State of Haryana v. A. Kumar Bansal Cited by the petitioners through their counsel; the opinion records reliance but does not describe the principle taken from this authority. The opinion notes that counsel placed reliance on this decision; it does not otherwise analyse or expressly apply that case in the Court's reasoning beyond recording its citation.

Court's Reasoning and Analysis

The court’s analysis proceeded from the statutory text and the undisputed chronology. The key statutory provision considered was section 25(3) and (4) of the Drugs and Cosmetics Act (reports of Government Analysts and the right to seek reanalysis at the Central Drugs Laboratory).

The court identified the following legal and factual points, and applied them sequentially:

  1. Textual requirement of section 25(3): a report signed by a Government Analyst is prima facie conclusive unless the person from whom the sample was taken notifies in writing the Inspector or the Court within twenty-eight days of receipt of the report that he intends to adduce evidence in controversion.
  2. Application of the statutory timeline to the facts: the copy of the Government Analyst's report was supplied to the accused on 26-5-1994; the accused notified the Drug Inspector in writing on 18-6-1994 (within 28 days) of their intention to adduce evidence in controversion and requested reanalysis at the Central Drugs Laboratory.
  3. Legal consequence of notifying the Inspector (as opposed to the Court): the statute permits notification either to the Inspector or to the Court before which proceedings are pending; notification to either forum within 28 days satisfies the statutory requirement. Thus, once the accused notified the Inspector within 28 days, the requirement of section 25(3) was met and it was unnecessary for the accused to immediately approach the Court.
  4. Role of section 25(4): once the accused has so notified, it is for the Court (on its own motion or at the request of either party) to direct that the sample be sent for reanalysis to the Central Drugs Laboratory. The Inspector, upon receiving such notification, had an obligation to take steps to facilitate that process by approaching the Magistrate.
  5. Application of law to conduct of the Drug Inspector and Magistrate: in the present case the Drug Inspector, despite receiving the accused's written intimation on 18-6-1994, did not immediately move the Magistrate and allowed time to lapse; consequently the accused were deprived of the statutory opportunity to secure reanalysis and the conclusive certificate of the Central Drugs Laboratory.
  6. Reliance on precedent: the court applied the observations from Municipal Corporation of Delhi v. Ghisa Ram (AIR 1967 SC 970), which emphasize that the prosecution must proceed in a manner that does not deny the accused the statutory right to reanalysis by the Central Laboratory, since that certificate supersedes the Public Analyst's report and denial of this right prejudices the accused.
  7. Conclusion from combined statutory reading and precedent: because the accused had duly notified the Inspector within 28 days and because the Inspector failed to take the required prompt steps under section 25(4), the prosecution was materially prejudiced; the trial court's finding of wilful delay by the accused was found to be misconceived and unsustainable in law.

The court expressly found fault with the inaction of the Government servant (the Drug Inspector), describing it as resulting in deprivation of statutory rights and causing prejudice to the accused and to the integrity of the prosecution.

Holding and Implications

Holding: IMPUGNED ORDER DATED 24-10-1994 QUASHED; COMPLAINT (CRIMINAL) CASE NO. 21 OF 1994 DISMISSED.

Immediate implications:

  • The Additional Chief Judicial Magistrate's order of 24-10-1994 (which had rejected the petitioners' application for dismissal and discharge) was quashed and set aside.
  • The criminal complaint instituted on the complaint of the Respondent-Drug Inspector (Complaint (Cr.) Case No. 21 of 1994) is dismissed as a consequence of the deprivation of the petitioners' statutory right to reanalysis.

Broader implications and precedent:

  • The opinion applies existing authority (notably Municipal Corporation of Delhi v. Ghisa Ram) to emphasize the protection of an accused's statutory right to seek reanalysis at the Central Drugs Laboratory. The court did not purport to create new law but applied established principles to the facts before it.
  • No novel principle of law was announced; the decision's effect is confined to the parties and to the legal conclusion that the prosecution was vitiated on the particular facts (notification within 28 days followed by prosecutorial inaction resulting in denial of the reanalysis right).

Order accordingly.

    Zim Laboratories Ltd. v. State Of Maharashtra

    1. Heard Shri Parchure, learned counsel for the petitioners and Shri Deshpande, learned Additional Public Prosecutor for the respondent-State.

    2. The present Criminal Writ Petition is directed against the order dated 3-2-1998 passed by the 3rd Additional Sessions Judge, Nagpur in Criminal Revision Application No. 1806 of 1995, whereby the Revisional Court dismissed the revision preferred by the complainant and confirmed the order dated 24-10-1994 passed by the Additional Chief Judicial Magistrate, Nagpur below Ex. 4 in Complaint (Cr.) Case No. 21 of 1994.

    3. It will be appropriate to consider few relevant facts which have given rise to the controversy in question. Petitioner No. 1 is the Public Limited Company engaged in manufacture and supply of drugs and medicines. It is a licensed manufacturer of medicines. The Complainant is the Drug Inspector, who was serving at the relevant time in the office of the Joint Commissioner, Food and Drugs Administration, Nagpur and is empowered to enforce the provisions of the Drugs and Cosmetics Act and Rules. Petitioner No. 1 is manufacturing Ampicillin and Cloxacillin capsules under the Brand name “Zimlox”. The said medicine manufactured by petitioner No. 1 Company is usually marketed through Universal Medikit Private Limited, Nagpur, who is the principal distributor appointed for the purpose.

    4. On 26-5-1994, the Drug Inspector, Chandrapur visited the factory of Petitioner No. 1 and handed over the copy of the report and test of Analysis of the drug “Zimlox” sent by the Government Analyst, Bombay, declaring the sample of said drug sent to him for analysis, “as not of standard quality as the quantity of its principle ingredients in the sample was found to be less than the limit prescribed”. A portion of the sample of the said drug was also delivered by the said Drug Inspector to the Technical Director of the Company i.e present Petitioner No. 11. After the receipt of the above referred report of the Government Analyst, Petitioner No. 1 sent a letter to the Drug Inspector on 18-6-1994 informing him that the report of the Government Analyst declaring the sample of the above referred drug as not of standard quality was not acceptable to petitioner No. 1 and he intended to lead evidence in controversion of the said Government Analyst report. Petitioner No. 1 further requested to send a portion of the sample of the drug to the Central Drugs Laboratory for reanalysis and the petitioner was ready to bear the cost involved in respect of the same.

    5. The Drug Inspector after the receipt of the above referred letter dated 18-6-1994 sent by petitioner No. 1 Company, handed over the case papers with the remaining portion of the sample to the office of the Joint Commissioner (Nagpur Division), Food & Drugs Administration (M.S), Nagpur. The said authority by its letter dated 13-7-1994 acknowledged the receipt of the letter dated 18-6-1994 and informed petitioner No. 1 Company to approach the Court concerned for obtaining the necessary direction to send the sample of the drug for reanalysis to the Central Drugs Laboratory at Calcutta. The petitioner received the said letter dated 13-7-1994 on 19-7-1994.

    6. Petitioner No. 1 presented an application before the Additional Chief Judicial Magistrate, Nagpur on 28-7-1994 requesting to direct the respondent-Complainant to deposit the portion of sample for sending it to Central Drugs Laboratory, Calcutta for reanalysis. The said application was registered as Criminal Application No. 12 of 1994. The Additional Chief Judicial Magistrate, Nagpur issued notice to the respondent-Complainant for submission of sample of the drug in question in the Court for sending it for reanalysis to the Central Drugs Laboratory, Calcutta. The said notice was served on respondent-Complainant in the first week of August 1994 and was made returnable by the Court on 30-9-1994. The drug in question was due to expiry in the month of August 1994. However, the Drug Inspector did not submit the sample immediately upon the receipt of the notice issued by the Court. The respondent-Complainant thereafter on 31-8-1994 lodged a criminal complaint against the petitioners and the offence under section 18(a)(i) read with section 16 and punishable under section 27 of the Drugs and Cosmetics Act, before the Additional Chief Judicial Magistrate, Nagpur.

    7. The petitioners filed an application for dismissal of the complaint and discharge of the accused persons before the Additional Chief Judicial Magistrate, Nagpur mainly on the ground that the Complainant failed to follow the relevant provisions of Drugs and Cosmetics Act and also delayed the lodging of the prosecution against the petitioners which has deprived them of availing their available right to get the reanalysis of the sample done from the Central Drugs Laboratory, Calcutta. The Additional Chief Judicial Magistrate, Nagpur vide order dated 24-10-1994 rejected the application for dismissal of the complaint and discharge of the accused. The said order was thereafter came to be confirmed by the 3rd Additional Sessions Judge, Nagpur vide order dated 3-2-1998 by dismissing the Revision preferred by the petitioners. Hence the present Writ Petition.

    8. Shri Parchure, the learned Counsel for the petitioners contended that because of failure on the part of the Drug Inspector to follow and comply with the provisions of section 25(3)(4) of the Drugs and Cosmetics Act, 1940, the entire prosecution in the instant case vitiated and complaint is liable to be dismissed. The learned Counsel contended that in the instant case the report of the Government Analyst in respect of the sample in question was delivered to the petitioners by the complainant on 26-5-1994. The petitioners within 28 days from the date of the receipt of the said report informed the complainant-Drug Inspector vide letter dated 18-6-1994 that the portion of the sample obtained by him be sent to the Central Drugs Laboratory, Calcutta for reanalysis of the said sample. It is further contended that similar request was also made to the Court while presenting the application dated 28-7-1994. It is further submitted that under sub-section (3) of section 25 of the Act, the petitioners were required to complete the above referred formality and thereafter the complainant-Inspector ought to have taken necessary steps immediately to get the reanalysis done of the sample through the Central Drugs Laboratory, Calcutta. It is further submitted that the Additional Chief Judicial Magistrate also could have issued direction to arrange to send the sample to Central Drugs Laboratory, Calcutta for the purposes of reanalysis. However, the learned counsel contended that neither the Drug Inspector nor the Additional Chief Judicial Magistrate had taken prompt steps in the matter and allow the time to lapse which in fact deprived the petitioners of their valuable legitimate right to get the reanalysis done through the Central Drugs Laboratory, Calcutta. The learned Counsel, therefore, submitted that the entire prosecution in the instant case is vitiated and not maintainable.

    9. The learned counsel for the petitioners in order to substantiate the contentions raised by him, placed reliance on the judgment reported in 1997 (2) Mh. L.J 629, Ramanbhai v. S.R Sharma; judgment of the Punjab & Haryana High Court reported in 1995 Drugs Cases 72, State of Haryana v. A. Kumar Bansal, and decision of the Apex Court reported in AIR 1967 SC 970, Municipal Corporation Of Delhi v. Ghisa Ram Ram.

    10. Shri Deshpande, the learned Additional Public Prosecutor appearing on behalf of the State supported the impugned order. The learned counsel contended that there is a wilful delay caused by the petitioners in approaching the Court for necessary direction regarding sending of sample to the Central Drugs Laboratory, Calcutta. It is contended that the report of Government Analyst was received by the complainant on 8-2-1994. The said report was supplied to the accused on 26-5-1994. Petitioner No. 1 on 18-6-1994 given intimation in writing to the Drug Inspector that they challenge the report of the Government Analyst. On 28-7-1994, the petitioners moved the Misc. Criminal Application No. 12 of 1994, before the Additional Chief Judicial Magistrate, Nagpur for sending the part of the sample to the Central Drugs Laboratory, Calcutta. The learned Additional Public Prosecutor for the State submitted that there was an unreasonable unexplained delay on the part of the petitioners to move the Court for necessary orders. It is further contended that the petitioners were supplied a copy of the report of the Government Analyst on 26-5-1994. There was no need for the petitioners to wait till 28-7-1994 and they could have immediately approached the Court for obtaining necessary directions regarding sending part of the sample to the Central Drugs Laboratory, Calcutta. The learned Additional Public Prosecutor contended that the delay caused by the petitioners is deliberate and wilful and with a view to allow the time to lapse since the drug in question was due to expire in the month of August 1994. The learned Additional Public Prosecutor, therefore, submitted that in the given set of circumstances, the petitioners are not entitled to get the benefit of the right conferred under section 25(3) and (4) of the Drugs and Cosmetics Act, 1940, and the impugned order is just and proper.

    11. In order to appreciate the contentions raised by the learned counsel for the petitioners, it will be appropriate to take into consideration certain undisputed facts, such as the sample in question was drawn on 26-10-1993. The drug in question was due to expire in the month of August 1994. The report of the Government Analyst was received by the Complainant-Drug Inspector on 8-2-1994. The copy of the said report was supplied to the accused on 26-5-1994. The accused - Company on 18-6-1994 gave intimation in writing to the Drug Inspector that they challenge the report of the Public Analyst and on 28-7-1994, the accused Company presented the Misc. Criminal Application No. 12 of 1994 for sending the part of the sample to the Central Drugs Laboratory, Calcutta. On the back drop of the above referred undisputed facts, it will be appropriate to consider the relevant provisions of law. Section 25 of the Act deals with the Reports of Government Analysts. sub-section (3) of section 25 reads thus:

    “(3) Any document purporting to be a report signed by a Government Analyst under this Chapter shall be evidence of the facts stated therein, and such evidence shall be conclusive unless the person from whom the sample was taken (or the person whose name, address and other particulars have been disclosed under section 18-A) has, within twenty-eight days of the receipt of a copy of the report, notified in writing the Inspector or the Court before which any proceedings in respect of the sample are pending that he intends to adduce evidence in controversion of the report.

    12. sub-section (3) of section 25 contemplates that the report signed by the Government Analyst shall be evidence of the facts stated therein and such evidence shall be conclusive unless the person from whom the sample was taken, within 28 days of the receipt of a copy of the report, notified in writing the Inspector or the Court before which any proceedings in respect of the sample are pending, his intention to adduce evidence in controversion of the report.

    13. The plain reading of the above referred sub-section (3) of section 25 of the Act makes it clear that after the receipt of the report of the Government Analyst by the accused, in case the accused is intending to adduce evidence in controversion of the said report, he is required to notify in writing the Inspector or the Court before which any proceedings in respect of the sample are pending, within 28 days from the date of receipt of such report.

    14. Sub-section (4) of section 25 of the Act contemplates that where a person has under sub-section (3) notified his intention of adducing evidence in controversion of a Government Analyst's report, the Court may, of its own motion or in its discretion at the request either of the complainant or the accused cause the sample of the drug produced before the Magistrate under sub-section (4) of section 23 to be sent for test or analysis to the said Laboratory, which shall make the test or analysis and report in writing signed by, or under the authority of, the Director of the Central Drugs Laboratory, the result thereof, and such report shall be conclusive evidence of the facts stated therein.

    15. In the instant case, it is not disputed that within 28 days from the receipt of the report of the Government Analyst, the accused Company given intimation by letter dated 18-6-1994 to the Complainant-Drug Inspector conveying their intention to adduce evidence in controversion of the report of the Government Analyst. The requirement as per sub-section (3) of section 25 of the Act is that the accused is required to notify in writing to the Inspector or the Court before which any proceedings in respect of the sample are pending, within 28 days from the receipt of the copy of the report of the Government Analyst, his intention to adduce evidence in controversion of the said report. It is, therefore, clear that if the accused conveys his above referred intention to the Inspector within 28 days from the receipt of a copy of the report of the Government Analyst, in my opinion, the requirement of the section is complete. Hence, in the instant case, the finding arrived at by the trial Court that there was a wilful delay on the part of the accused is not only misconceived but the same is unsustainable in law. It is to be noted that sub-section (3) of section 25 contemplates two forums to be approached by the accused within 28 days from the receipt of a copy of the report of the Government Analyst. First, the Inspector and the second is the Court before whom the proceedings in respect of the sample are pending. The accused is entitled to approach any one of the above referred authorities within the stipulated period of 28 days and since in the instant case, the accused has approached the Inspector within 28 days, as contemplated by sub-section (3) of section 25 of the Act, it cannot be said that there was any delay whatsoever on the part of the accused to move the authority concerned as contemplated under sub-section (3) of section 25 of the Act.

    16. Sub-section (4) of section 25 contemplate the procedure to be adopted by the Court when the accused notifies in writing his intention to adduce evidence in controversion of the report of the Government Analyst. The Court in such a situation on its own motion or in its discretion at the request either of the complainant or the accused cause the sample of the drug produced before it under sub-section (4) of section 23 to be sent for the necessary test or analysis.

    17. In the instant case, as stated above, the Drug Inspector was notified by the accused-company on 18-6-1994 i.e within the stipulated period of 28 days about their intention to adduce evidence in controversion of the report. Therefore, it was not only necessary but incumbent upon the Drug Inspector to immediately move the Magistrate, as contemplated under sub-section (4) of section 25 of the Act, for necessary direction. However, in the instant case, it is really surprising that the Drug Inspector did not do anything in spite of the intimation by letter dated 18-6-1994. It is really unfortunate that the Government servants, entrusted with the public duty, are so casual and callous in discharging their statutory duties which, in fact, results in causing grave injustice to the society at large. The inaction on the part of the concerned officer also results in depriving the citizens from exercising their available statutory rights which ultimately adversely affects the prosecution and the Courts are required to quash the same.

    18. The present controversy in question is clearly covered by the observations made by the Apex Court, particularly in para 7 of its judgment reported in AIR 1967 SC 970, Municipal Corporation Of Delhi v. Ghisa Ram Ram. Those are:—

    “It appears to us, that when a valuable right is conferred by section 13(2) of the Act on the vendor to have the sample given to him analysed by the Director of Central Food Laboratory, it is to be expected that the prosecution will proceed in such a manner that right will not be denied to him. The right is a valuable one, because the certificate of the Director supersedes the report of the Public Analyst and is treated as conclusive evidence of its contents. Obviously, the right has been given to the vendor in order that, for his satisfaction and proper defence, he should be able to have the sample kept in his charge analysed by a greater expert whose certificate is to be accepted by Court as conclusive evidence. In a case where there is denial of this right on account of the deliberate conduct of the prosecution, we think that the vendor, in his trial, is so seriously prejudiced that it would not be proper to uphold his conviction on the basis of the report of the Public Analyst, even though that report continues to be evidence in the case of the facts contained therein.”

    19. In the present case, the petitioner-accused in view of the provisions of sub-section (3) of section 25, informed the complainant within 28 days from the date of receipt of the report his intention to adduce evidence in controversion of the said report of the Government Analyst. However, because of the failure on the part of the complainant to take prompt appropriate steps in this regard, the petitioner was deprived of his valuable statutory right which has affected the prosecution adversely.

    20. In the instant case, the Drug Inspector in spite of the receipt of the intimation from the petitioner-company on 18-6-1994, did not do anything at all and allow the time to lapse which ultimately resulted in denial of opportunity to the petitioners for getting the part of the sample of the drug reanalysed from the Central Drugs Laboratory, Calcutta which, in fact, has further resulted in depriving the petitioners from exercising their valuable statutory right which, in my opinion, goes to the root of the matter and adversely affects the prosecution. It is no doubt true that the report of Government Analyst continues to be the evidence in a case of the facts contained therein. However, right of the accused to get the sample analysed from the Central Drugs Laboratory, Calcutta is a valuable right since the certificate of Central Drugs Laboratory supersedes the report of the Government Analyst and is treated as conclusive evidence of its contents. In that view of the matter, in my opinion, the impugned order is not just and proper and the same is devoid of substance and misconceived.

    21. In the result, the impugned order dated 24-10-1994 passed by the Additional Chief Judicial Magistrate, Nagpur is hereby quashed and set aside and the Complaint (Criminal) Case No. 21 of 1994 instituted on the complaint of the Respondent-Complainant is dismissed.

    Order accordingly.
    Use AI to get other relevant cases.

    Comments

    Zim Laboratories Ltd. v. State Of Maharashtra
    (Feb 3, 1999)